These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11092039)

  • 1. Prognosis of metastatic melanoma: no correlation of tyrosinase mRNA in bone marrow and survival time.
    Waldmann V; Wacker J; Deichmann M; Jäckel A; Bock M; Näher H
    Recent Results Cancer Res; 2001; 158():118-25. PubMed ID: 11092039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma.
    Waldmann V; Wacker J; Deichmann M; Näher H
    Dermatology; 2000; 201(1):6-9. PubMed ID: 10971051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of tyrosinase-specific mRNA in bone marrow is not more sensitive than in blood for the demonstration of micrometastatic melanoma.
    Waldmann V; Deichmann M; Bock M; Jäckel A; Näher H
    Br J Dermatol; 1999 Jun; 140(6):1060-4. PubMed ID: 10354071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
    Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
    Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.
    Ghossein RA; Coit D; Brennan M; Zhang ZF; Wang Y; Bhattacharya S; Houghton A; Rosai J
    Clin Cancer Res; 1998 Feb; 4(2):419-28. PubMed ID: 9516931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression.
    Reinhold U; Lüdtke-Handjery HC; Schnautz S; Kreysel HW; Abken H
    J Invest Dermatol; 1997 Feb; 108(2):166-9. PubMed ID: 9008229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients.
    Farthmann B; Eberle J; Krasagakis K; Gstöttner M; Wang N; Bisson S; Orfanos CE
    J Invest Dermatol; 1998 Mar; 110(3):263-7. PubMed ID: 9506446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma.
    Quereux G; Denis M; Khammari A; Lustenberger P; Dreno B
    Dermatology; 2001; 203(3):221-5. PubMed ID: 11701975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.
    Tsukamoto K; Ueda M; Hirata S; Osada A; Kitamura R; Takahashi T; Ichihashi M; Shimada S
    J Dermatol Sci; 2000 Jun; 23(2):126-31. PubMed ID: 10808130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients.
    Carrillo E; Prados J; Marchal JA; Boulaiz H; Martínez A; Rodríguez-Serrano F; Caba O; Serrano S; Aránega A
    Dis Markers; 2006; 22(3):175-81. PubMed ID: 16788251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of prognostic importance of reverse-transcriptase polymerase chain reaction detection of circulating messenger RNA in patients with melanoma.
    Ranieri JM; Wagner JD; Wiebke EA; Azuaje R; Smith ML; Wenck S; Daggy J; Coleman JJ
    Plast Reconstr Surg; 2005 Apr; 115(4):1058-63. PubMed ID: 15793446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinase mRNA RT-PCR analysis as an additional diagnostic tool for the identification of melanoma cells in biological fluid samples other than blood: a preliminary report.
    Savoia P; Quaglino P; Osella-Abate S; Comessatti A; Nardò T; Bernengo MG
    Int J Biol Markers; 2005; 20(1):11-7. PubMed ID: 15832768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour microdissemination and survival in metastatic melanoma.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Franzke A; Sel S; Atzpodien E; Buer J
    Anticancer Res; 2000; 20(5B):3619-24. PubMed ID: 11131671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned?
    Ghossein RA; Bhattacharya S; Coit DG
    Recent Results Cancer Res; 2001; 158():63-77. PubMed ID: 11092034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
    Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.